Independent pharmacies across the commonwealth are closing their doors, but a recent report claims the commonwealth‘s overspending of Medicaid funding on prescription drugs is to blame.

The cost of a drug used to treat a rare liver disorder rose by more than 1,500 percent, according to Sanders’s office.

Trump issued an executive order (EO) to protect the security of the U.S. drug market by ordering a list of essential ...

Prescription drug prices are complex and vary across insurance, pharmacies, and discount platforms like GoodRx. Learn how PBMs, Medicare Part D, and new models like Cost Plus Drugs affect your costs ...

Starting October 1, the U.S. is taking a hard stance on pharmaceutical manufacturing: Imported brand-name, patented drugs ...

AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients at a discount of up ...

The Louisiana Legislature didn't ban PBM vertical integration. But state leaders are still working on ways to limit to power ...

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...

Matt Cover’s Sept. 23 op-ed sought to paint pharmacy benefit managers (PBMs) as good actors trying to keep prices low for ...

On Monday, a state-funded committee in Louisiana gave Mark Cuban’s Cost Plus Drug Company a taxpayer-funded microphone to ...

Andrea Iannucci, PharmD, BCOP, assistant chief pharmacist at UC Davis Health, spoke with The American Journal of Managed Care ® (AJMC ®) about the accessibility of new formulary drugs in oncology and ...